ONTARGET: ARB as effective as ACE inhibitor, no need for combination - Endocrine Today
 Pravda | ONTARGET: ARB as effective as ACE inhibitor, no need for combination Endocrine Today - CHICAGO - Telmisartan has fewer side effects than ramipril in patients with vascular disease or diabetes, but the efficacy of the two are similar, according to data from the ONTARGET trial presented today. New Blood Pressure Medication Has Fewer Side Effects, Global Study ... ACE Inhibitor as Effective as More Expensive Blood Pressure Drug |